<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>AIMS/HYPOTHESIS: <z:hpo ids='HP_0009800'>Gestational diabetes</z:hpo> is a <z:e sem="disease" ids="C0025517" disease_type="Disease or Syndrome" abbrv="">metabolic disorder</z:e> affecting 2-5% of women and is a predictor of <z:hpo ids='HP_0001513'>obesity</z:hpo>, Type 2 <z:hpo ids='HP_0000819'>diabetes mellitus</z:hpo> and <z:e sem="disease" ids="C0007222" disease_type="Disease or Syndrome" abbrv="CVD">cardiovascular disease</z:e> </plain></SENT>
<SENT sid="1" pm="."><plain><z:hpo ids='HP_0000855'>Insulin resistance</z:hpo>, a characteristic of <z:hpo ids='HP_0009800'>gestational diabetes</z:hpo> and <z:hpo ids='HP_0001513'>obesity</z:hpo>, is correlated with the fatty acids profile of the red cell and skeletal muscle membranes </plain></SENT>
<SENT sid="2" pm="."><plain>We investigated the plasma and red cell fatty acid status of <z:hpo ids='HP_0009800'>gestational diabetes</z:hpo> </plain></SENT>
<SENT sid="3" pm="."><plain>The effect of <z:hpo ids='HP_0001513'>obesity</z:hpo> on membrane fatty acids was also examined </plain></SENT>
<SENT sid="4" pm="."><plain>METHODS: Fasting blood obtained at diagnosis was analysed for the fatty acids in plasma <z:chebi fb="3" ids="15354">choline</z:chebi> phosphoglycerides and red cell <z:chebi fb="3" ids="15354">choline</z:chebi> and <z:chebi fb="0" ids="16000,23981">ethanolamine</z:chebi> phosphoglycerides </plain></SENT>
<SENT sid="5" pm="."><plain>RESULTS: There were reductions in <z:chebi fb="0" ids="15843">arachidonic acid</z:chebi> (controls 10.74+/-2.35 vs <z:hpo ids='HP_0009800'>gestational diabetes</z:hpo> 8.35+/-3.49, p&lt;0.01) and <z:chebi fb="0" ids="36005">docosahexaenoic acid</z:chebi> (controls 6.31+/-2.67 vs <z:hpo ids='HP_0009800'>gestational diabetes</z:hpo> 3.25+/-2.00, p&lt;0.0001) in the red cell <z:chebi fb="3" ids="15354">choline</z:chebi> phosphoglycerides in <z:hpo ids='HP_0009800'>gestational diabetes</z:hpo> </plain></SENT>
<SENT sid="6" pm="."><plain>A similar pattern was found in the <z:chebi fb="0" ids="16000,23981">ethanolamine</z:chebi> phosphoglycerides </plain></SENT>
<SENT sid="7" pm="."><plain>Moreover, the arachidonic and <z:chebi fb="0" ids="36005">docosahexaenoic acids</z:chebi> <z:mpath ids='MPATH_63'>depletion</z:mpath> in the red cell <z:chebi fb="3" ids="15354">choline</z:chebi> phosphoglycerides was much greater in overweight/<z:mp ids='MP_0001261'>obese</z:mp> <z:hpo ids='HP_0009800'>gestational diabetes</z:hpo> (<z:chebi fb="0" ids="15843">arachidonic acid</z:chebi>=7.49+/-3.37, <z:chebi fb="0" ids="36005">docosahexaenoic acid</z:chebi>=2.98+/-2.18, p&lt;0.01) compared with lean <z:hpo ids='HP_0009800'>gestational diabetes</z:hpo> (<z:chebi fb="0" ids="15843">arachidonic acid</z:chebi>=10.03+/-2.74, <z:chebi fb="0" ids="36005">docosahexaenoic acid</z:chebi>=4.18+/-1.42) </plain></SENT>
<SENT sid="8" pm="."><plain>CONCLUSION/INTERPRETATION: Apparently <z:mpath ids='MPATH_458'>normal</z:mpath> plasma <z:chebi fb="3" ids="15354">choline</z:chebi> phosphoglycerides fatty acids profile in the gestational diabetic women suggested that membrane <z:chebi fb="23" ids="18059">lipid</z:chebi> abnormality is associated specifically with perturbation in the membrane </plain></SENT>
<SENT sid="9" pm="."><plain>The fact that the <z:chebi fb="23" ids="18059">lipid</z:chebi> abnormality is more pronounced in the outer leaflet of the membrane where most of receptor binding and enzyme activities take place might provide an explanation for the increased <z:hpo ids='HP_0000855'>insulin resistance</z:hpo> in <z:hpo ids='HP_0009800'>gestational diabetes</z:hpo> and <z:hpo ids='HP_0001513'>obesity</z:hpo> </plain></SENT>
</text></document>